John Arne Dahl

Oslo University Hospital

Norway

Research Interests

Explore related searches

Professors in Norway Professors in Immunology Immunology professors in Norway

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Collaborators (7)

Anette Hjartåker

University of Oslo

NORWAY

View details

Stine Ulven

Head of Department/Professor

University of Oslo

NORWAY

View details

Kirsten Holven

University of Oslo

NORWAY

View details

Gunnveig Grødeland

University of Oslo

NORWAY

View details

Sherif Khodeer

Oslo University Hospital

NORWAY

View details

Evi Stavrou

Tenured Associate Professor

Case Western Reserve University School of Medicine

UNITED STATES

View details

Cathrine Lund Hadley

MD PhD/Head of Clinical Development

Age Labs AS

NORWAY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

John Arne Dahl

Research Interests

Explore related searches

Contact this professor

Articles (10)

Post-acute symptoms 3-15 months after COVID-19 among unvaccinated and vaccinated individuals with a breakthrough infection

Prevention of covid-19 and other acute respiratory infections with cod liver oil supplementation, a low dose vitamin D supplement: quadruple blinded, randomised placebo controlled trial.

Cri du chat syndrome patients have DNA methylation changes in genes linked to symptoms of the disease.

Breakthrough infections with the omicron and delta variants of SARS-CoV-2 result in similar re-activation of vaccine-induced immunity.

EWAS of post-COVID-19 patients shows methylation differences in the immune-response associated gene, IFI44L, three months after COVID-19 infection.

ALKBH5 regulates somatic cell reprogramming in a phase-specific manner

The use of public transport and contraction of SARS-CoV-2 in a large prospective cohort in Norway.

Persisting symptoms three to eight months after non-hospitalized COVID-19, a prospective cohort study.

Intestinal-epithelial LSD1 controls goblet cell maturation and effector responses required for gut immunity to bacterial and helminth infection

Analysis of epigenetic aging in vivo and in vitro: Factors controlling the speed and direction

Collaborators (7)

Anette Hjartåker

Stine Ulven

Kirsten Holven

Gunnveig Grødeland

Sherif Khodeer

Evi Stavrou

Cathrine Lund Hadley

Make your next move.